110 results
Page 2 of 6
6-K
EX-99.1
3b65de
12 Sep 22
Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for etigilimab plus anti-PD1 therapy
8:17am
6-K
EX-99.1
xff9qv 6wtans5q1
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
g2j77
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-99.1
ff1b5u1dssbpan1cl
2 Jun 22
Mereo Also Updates Capital Allocation and Portfolio Prioritization Plan
9:07am
6-K
EX-99.1
xkpb6wcyh
26 May 22
Current report (foreign)
5:11pm
6-K
EX-3.1
oipq b78afngmsr
17 May 22
Current report (foreign)
8:26am
6-K
y2254zd86
9 May 22
Current report (foreign)
8:06am
6-K
EX-99.1
y3m3rj ta7
9 May 22
Current report (foreign)
8:06am
6-K
EX-99.1
22r9j 4pglk45u
31 Mar 22
Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
4:18pm
6-K
kmcolk4
14 Mar 22
Current report (foreign)
10:05am
6-K
EX-99.1
up83qr r97tgb
14 Mar 22
Current report (foreign)
10:05am
6-K
EX-99.1
5hahftzv9s
22 Dec 21
Alvelestat reported safe and well-tolerated in patients with COVID-19
7:45am